Biomerica (BMRA) Shares Outstanding (Diluted Average) (2011 - 2026)

Biomerica has disclosed Shares Outstanding (Diluted Average) across 12 years of filings, most recently posting $2.9 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $2.9 million, up 22.56% year-over-year; the trailing twelve-month figure through Feb 2026 was $2.9 million (up 22.56% YoY), and the FY2025 annual result was $2.3 million, up 9.22% from the prior year.
• Shares Outstanding (Diluted Average) came in at $2.9 million for Q1 2026 at Biomerica, down from $2.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $16.8 million in Q3 2023 to a low of $2.1 million in Q2 2024.
• The 5-year median for Shares Outstanding (Diluted Average) is $12.7 million (2022), against an average of $8.8 million.
• Across the five-year window, Shares Outstanding (Diluted Average) plunged 87.5% in 2024 and jumped 37.09% in 2025, its largest moves.
• Biomerica's Shares Outstanding (Diluted Average) stood at $13.5 million in 2022, then grew by 25.02% to $16.8 million in 2023, then slumped by 87.39% to $2.1 million in 2024, then jumped by 37.09% to $2.9 million in 2025, then fell by 1.93% to $2.9 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $2.9 million (Q1 2026), $2.9 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.